Comment on "Acute Retinal Necrosis: Is the Current Valacyclovir Regimen Adequate?"

Joanna von Hofsten^{1

2}, Marie Studahl³

Affiliations

¹ Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
² Department of Ophthalmology, Halland Hospital Halmstad, Halmstad, Sweden.
³ Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Comment

Joanna von Hofsten et al. Ocul Immunol Inflamm. 2022 Jul.

. 2022 Jul;30(5):1289.

doi: 10.1080/09273948.2020.1860234. Epub 2021 Jan 29.

Joanna von Hofsten^{1

2}, Marie Studahl³

¹ Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
² Department of Ophthalmology, Halland Hospital Halmstad, Halmstad, Sweden.
³ Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

No abstract available

Comment on

Acute Retinal Necrosis: Is The Current Valacyclovir Regimen Adequate?
Senter G, Nascimento HMD, Belfort R Junior. Senter G, et al. Ocul Immunol Inflamm. 2020 May 18;28(4):665-666. doi: 10.1080/09273948.2019.1616771. Epub 2019 Aug 12. Ocul Immunol Inflamm. 2020. PMID: 31401907